The work contributes significantly to understanding the role of genetic polymorphisms in liver fibrosis associated with MASLD, highlighting the relevance of the MTARC1 gene as a protective factor. Here, MTARC1 is linked to metabolic dysfunction-associated steatotic liver disease.